Radionetics Oncology, Inc. is a clinical stage company focused on the discovery and development of novel radiopharmaceuticals for the treatment of a wide range of oncology indications and is poised to capitalize on the increasing demand for novel radiotherapeutics. Radionetics Oncology is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Global Investments and has entered into a strategic agreement with Eli Lilly. Radionetics is advancing a pipeline of first-in-class small molecule radioligands targeting cell surface receptors for the treatment of a broad range of cancers, including breast cancer, lung cancer, and other indications of high unmet need. For more information, visit https://radionetics.com. Radionetics Oncology is seeking a Director, Molecular Imaging to serve as a subject matter expert in nuclear imaging technologies, supporting the development and execution of radiopharmaceutical programs. This individual will lead imaging strategy, oversee image quality control and workflow processes, and provide expert review and interpretation of imaging data across preclinical and clinical studies. This role is highly cross-functional, partnering closely with R&D, Clinical Development, and external collaborators to ensure imaging data is accurate, reproducible, and aligned with program objectives. The ideal candidate brings deep expertise in nuclear imaging modalities and a strong track record of driving operational excellence in imaging workflows.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director